Kurs CombiMatrix Corp

Aktien

10.11.17	CombiMatrix Corporation Stockholders Approve Merger Agreement With Invitae Corporation
06.11.17	CombiMatrix Corporation Reports Third Quarter 2017 Financial and Operating Results
02.11.17	CombiMatrix Corporation Reminds Shareholders to Vote "FOR" the Merger With Invitae Corporation
01.11.17	Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend CombiMatrix Corporation Shareholders Vote "FOR" the Proposed Merger with Invitae Corporation
20.10.17	CombiMatrix to Present New Data from a Large-Scale Analysis of Genomic Abnormalities Impacting Multiple Stages of Human Growth and Development Starting from Conception through Childhood at the American Society of Human Genetics Annual Meeting

Manager	Titel	Alter	Seit
Sean George CEO	Vorstandsvorsitzender	52	-
Shelly Guyer DFI	Finanzdirektor/CFO	65	-
Elias Bendekgey CEO	Vorstandsvorsitzender	68	14.11.2017

Verwaltungsratsmitglied	Titel	Alter	Seit
Thomas Akin CHM	Vorsitzender	73	01.05.1998

Zu einer Liste hinzufügen 0 ausgewählt Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein Einloggen Anmeldung	%	% 5 Tage	Perf. 1 Jahr	Perf. 3 Jahre	Marktkap.($)
COMBIMATRIX CORP	-.--%	-17.76%	-	-	0
NATERA, INC.	+0.92%	+11.69%	+153.15%	+817.41%	59.47 Mrd.
LABCORP HOLDINGS INC.	+0.22%	-3.45%	+10.35%	+50.78%	25.11 Mrd.
SONIC HEALTHCARE LIMITED	-0.63%	-2.34%	-11.16%	-38.35%	6.52 Mrd.
RADNET, INC.	-0.73%	-6.86%	-6.74%	+154.37%	5.57 Mrd.
DR. LAL PATHLABS LIMITED	-0.46%	+2.92%	+22.23%	+61.31%	3.4 Mrd.
GENEDX HOLDINGS CORP.	-0.09%	-12.56%	-24.58%	+2’376.19%	2.64 Mrd.
NEOGENOMICS, INC.	-1.18%	-2.91%	+143.76%	+57.03%	2.48 Mrd.
FLEURY S.A.	+16.38%	+1.68%	+35.11%	+45.42%	2.27 Mrd.
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	+1.10%	+4.93%	+0.79%	-53.43%	2 Mrd.
Durchschnitt	+1.55%	-0.64%	+35.88%	+385.64%	12.16 Mrd.
Nach Marktkapitalisierung gewichteter Durchschnitt	+0.79%	+4.90%	+88.67%	+521.68%